The inflammation hypothesis in geriatric depression

No abstract is available for this paper.

• Publication year

  2011

• Venue

  International Journal of Geriatric Psychiatry

• Publication date

  2011-11-01

• Fields of study

  Medicine, Psychology

• Identifiers
  DOI 10.1002/gps.2672PMID 21370276PMCID PMC3160498
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• Depression is an inflammatory disease, but cell-mediated immune activation is the key component of depression.

  2011cited by this paper
• The role of microglia in central nervous system immunity and glioma immunology.

  2010cited by this paper
• Prospects for minocycline neuroprotection.

  2010cited by this paper
• A double-blind, randomized study of minocycline for the treatment of negative and cognitive symptoms in early-phase schizophrenia.

  2010cited by this paper
• The interleukin 1 beta (IL1B) gene is associated with failure to achieve remission and impaired emotion processing in major depression.

  2010cited by this paper
• Interleukin-1beta serum levels is increased in antidepressant-free elderly depressed patients.

  2010cited by this paper
• Increased soluble TNF receptor 2 in antidepressant-free patients with late-life depression.

  2010cited by this paper
• A meta-analysis of cytokines in major depression.

  2010cited by this paper
• Immune influence on adult neural stem cell regulation and function.

  2009cited by this paper
• Associations of Depression With C-Reactive Protein, IL-1, and IL-6: A Meta-Analysis

  2009cited by this paper
• Interleukin-6 is elevated in the cerebrospinal fluid of suicide attempters and related to symptom severity.

  2009cited by this paper
• Clinical trial of adjunctive celecoxib treatment in patients with major depression: a double blind and placebo controlled trial

  2009cited by this paper
• Immune activation in brain aging and neurodegeneration: too much or too little?

  2009cited by this paper
• Research advances in geriatric depression

  2009cited by this paper
• Interleukin-1 receptor antagonist and incident depressive symptoms over 6 years in older persons: the InCHIANTI study.

  2009cited by this paper
• Increased soluble tumor necrosis factor‐α receptors in patients with major depressive disorder

  2009cited by this paper
• Inflammation Causes Mood Changes Through Alterations in Subgenual Cingulate Activity and Mesolimbic Connectivity

  2009cited by this paper
• Interleukin-6 covaries inversely with hippocampal grey matter volume in middle-aged adults.

  2008cited by this paper
• Neuroinflammation Associated with Aging Sensitizes the Brain to the Effects of Infection or Stress

  2008cited by this paper
• Interleukin-6-(IL-6) plasma levels in depression and schizophrenia: comparison between the acute state and after remission

  2008cited by this paper
• Aging, microglial cell priming, and the discordant central inflammatory response to signals from the peripheral immune system

  2008cited by this paper
• Does minocycline have antidepressant effect?

  2008cited by this paper
• Inflammatory markers in late-life depression: results from a population-based study.

  2008cited by this paper
• Cognitive and neuroinflammatory consequences of mild repeated stress are exacerbated in aged mice.

  2008cited by this paper
• Microglial degeneration in the aging brain--bad news for neurons?

  2008influential reference
• Minocycline as Adjunctive Therapy for Schizophrenia: An Open-Label Study

  2008cited by this paper
• IL-1 cytokines in cardiovascular disease: diagnostic, prognostic and therapeutic implications.

  2008cited by this paper
• Antidepressant-like actions of minocycline combined with several glutamate antagonists.

  2008cited by this paper
• Associations of C-reactive protein and interleukin-6 with cognitive symptoms of depression: 12-year follow-up of the Whitehall II study

  2008cited by this paper
• Pro-inflammatory cytokines and treatment response to escitalopram in major depressive disorder.

  2008cited by this paper
• The hypothalamus-pituitary-adrenal axis

  2008cited by this paper
• Anti-inflammatory properties of desipramine and fluoxetine

  2007cited by this paper
• Interleukin-1beta but not tumor necrosis factor-alpha potentiates neuronal damage by quinolinic acid: protection by an adenosine A2A receptor antagonist.

  2007cited by this paper
• Cytokine imbalance in the pathophysiology of major depressive disorder.

  2007cited by this paper
• Plasma cytokine profiles in depressed patients who fail to respond to selective serotonin reuptake inhibitor therapy.

  2007cited by this paper
• Microglia serve as a neuroimmune substrate for stress-induced potentiation of CNS pro-inflammatory cytokine responses.

  2007cited by this paper
• The Immune System of the Brain

  2007cited by this paper
• Immunosenescence of ageing

  2007cited by this paper
• Interleukin‐1β but not tumor necrosis factor‐α potentiates neuronal damage by quinolinic acid: Protection by an adenosine A2A receptor antagonist

  2007cited by this paper
• Tumor Necrosis Factor Receptor 1 Is a Negative Regulator of Progenitor Proliferation in Adult Hippocampal Neurogenesis

  2006cited by this paper
• Effect of aging on the microglial response to peripheral nerve injury.

  2006cited by this paper
• Age and neuroinflammation: a lifetime of psychoneuroimmune consequences.

  2006cited by this paper
• Interleukin-6 in aging and chronic disease: a magnificent pathway.

  2006cited by this paper
• The cyclooxygenase-2 inhibitor celecoxib has therapeutic effects in major depression: results of a double-blind, randomized, placebo controlled, add-on pilot study to reboxetine

  2006cited by this paper
• P.2.a.001 The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder

  2006cited by this paper
• The role of IL-12 and TGF-beta1 in the pathophysiology of major depressive disorder.

  2006cited by this paper
• Etanercept and clinical outcomes, fatigue, and depression in psoriasis: double-blind placebo-controlled randomised phase III trial.

  2006cited by this paper
• Anterior cingulate activation and error processing during interferon-alpha treatment.

  2005cited by this paper
• Tumor necrosis factor-α and interleukin-18 modulate neuronal cell fate in embryonic neural progenitor culture

  2005cited by this paper
• Exaggerated neuroinflammation and sickness behavior in aged mice after activation of the peripheral innate immune system

  2005cited by this paper
• Astrocytes as targets for neuroprotective drugs.

  2005cited by this paper
• Increase in interleukin-1 beta in late-life depression

  2005cited by this paper
• Inflammatory markers and cardiovascular health in older adults.

  2005cited by this paper
• Increase in interleukin-1beta in late-life depression.

  2005cited by this paper
• IL‐6 levels decrease with SSRI treatment in patients with major depression

  2005cited by this paper
• Microglia‐derived tumor necrosis factor‐α exaggerates death of newborn hippocampal progenitor cells in vitro

  2005cited by this paper
• Depression in the elderly.

  2005cited by this paper
• Gene regulation and DNA damage in the ageing human brain

  2004cited by this paper
• How chronic inflammation can affect the brain and support the development of Alzheimer's disease in old age: the role of microglia and astrocytes

  2004cited by this paper
• Inflammatory proteins and depression in the elderly.

  2003cited by this paper
• In vitro immunoregulatory effects of antidepressants in healthy volunteers.

  2003cited by this paper
• Inflammatory markers and depressed mood in older persons: results from the Health, Aging and Body Composition study.

  2003influential reference
• Inflammatory Markers and Onset of Cardiovascular Events: Results From the Health ABC Study

  2003cited by this paper
• Inflammatory Blockade Restores Adult Hippocampal Neurogenesis

  2003cited by this paper
• Infliximab in refractory spondyloarthropathies : a multicentre 38 week open study

  2003cited by this paper
• Cytokines, insulin-like growth factor 1, sarcopenia, and mortality in very old community-dwelling men and women: the Framingham Heart Study.

  2003cited by this paper
• Aging and glial responses to lipopolysaccharide in vitro: greater induction of IL-1 and IL-6, but smaller induction of neurotoxicity.

  2003cited by this paper
• Immune-to-central nervous system communication and its role in modulating pain and cognition: Implications for cancer and cancer treatment.

  2003cited by this paper
• Interleukin-6 and risk of cognitive decline: MacArthur Studies of Successful Aging

  2002cited by this paper
• Prior stressor exposure sensitizes LPS-induced cytokine production.

  2002cited by this paper
• An Age-Related Decline in Interleukin-10 May Contribute to the Increased Expression of Interleukin-6 in Brain of Aged Mice

  2002cited by this paper
• Frontostriatal and limbic dysfunction in late-life depression.

  2002cited by this paper
• Cytokines and chemokines as mediators of protection and injury in the central nervous system assessed in transgenic mice.

  2002influential reference
• Immune response gene expression increases in the aging murine hippocampus.

  2002cited by this paper
• Plasma concentrations of interleukin-1beta, interleukin-6, soluble interleukin-2 receptor and tumor necrosis factor alpha of depressed patients in Japan.

  2001cited by this paper
• Plasma Concentrations of Interleukin-1β, Interleukin-6, Soluble Interleukin-2 Receptor and Tumor Necrosis Factor α of Depressed Patients in Japan

  2001cited by this paper
• Transformation of donor‐derived bone marrow precursors into host microglia during autoimmune CNS inflammation and during the retrograde response to axotomy

  2001cited by this paper
• The glossopharyngeal nerve as a novel pathway in immune-to-brain communication: relevance to neuroimmune surveillance of the oral cavity.

  2001cited by this paper
• Lack of a modulatory effect of imipramine on glucocorticoid-induced suppression of interferon-gamma and interleukin-10 production in vitro.

  2001cited by this paper
• Increased serum tumor necrosis factor alpha concentrations in major depression and multiple sclerosis.

  2001cited by this paper
• The in vitro immunosuppressive effects of moclobemide in healthy volunteers.

  2000cited by this paper
• Effects of serotonin and serotonergic agonists and antagonists on the production of interferon-gamma and interleukin-10.

  2000cited by this paper
• Gene-expression profile of the ageing brain in mice

  2000cited by this paper
• Plasma levels of interleukin-6, interleukin-10, and interleukin-1 receptor antagonist in depression: comparison between the acute state and after remission.

  2000cited by this paper
• Vagal immune-to-brain communication: a visceral chemosensory pathway.

  2000cited by this paper
• Minocycline inhibits caspase-1 and caspase-3 expression and delays mortality in a transgenic mouse model of Huntington disease

  2000cited by this paper
• Epidermal immunization by a needle-free powder delivery technology: Immunogenicity of influenza vaccine and protection in mice

  2000cited by this paper
• Effects of Serotonin and Serotonergic Agonists and Antagonists on the Production of Interferon-γ and Interleukin-10

  2000cited by this paper
• Differential effect of chronic antidepressant treatments on lipopolysaccharide-induced depressive-like behavioural symptoms in the rat.

  1999influential reference
• Tryptophan catabolism and T-cell tolerance: immunosuppression by starvation?

  1999cited by this paper
• Negative Immunoregulatory Effects of Antidepressants: Inhibition of Interferon-γ and Stimulation of Interleukin-10 Secretion

  1999cited by this paper
• Associations of elevated interleukin-6 and C-reactive protein levels with mortality in the elderly.

  1999cited by this paper
• Life stress, mood disturbance, and elevated interleukin-6 in healthy older women.

  1999cited by this paper
• Association of Interleukin‐6 and Other Biologic Variables with Depression in Older People Living in the Community

  1999cited by this paper
• Serum IL‐6 Level and the Development of Disability in Older Persons

  1999cited by this paper
• Increased interleukin-6 expression by microglia from brain of aged mice.

  1999cited by this paper
• The Role of the Vagus Nerve in Cytokine‐to‐Brain Communication

  1998cited by this paper
• The inflammatory response system and the availability of plasma tryptophan in patients with primary sleep disorders and major depression.

  1998cited by this paper
• Effect of desipramine on immunological parameters in mice, and their reversal by stress.

  1998cited by this paper
• Neurotrophins regulate the function of cultured microglia

  1998cited by this paper

• Remission is insufficient: predictors and mechanistic models of recurrence in late-life depression.

  2026cites this paper
• Multimodal MRI data fusion reveals distinct structural, functional and neurochemical correlates of depression in patients with Parkinson's disease

  2026cites this paper
• Mood Symptoms are Associated With Cognitive Status, Brain Amyloid-Beta Deposition, and Plasma Biomarkers

  2025cites this paper
• Decreased Mitochondrial DNA Integrity and Elevated Inflammatory Markers in Late-Life Depression: A Longitudinal Study

  2025cites this paper
• Identification and validation of an explainable machine learning model for vascular depression diagnosis in the older adults: a multicenter cohort study

  2025cites this paper
• Associations between inflammation and striatal dopamine D2-receptor availability in aging

  2025cites this paper
• Relationship between multimorbidity burden and depressive symptoms in older Chinese adults: A prospective 10-year cohort study.

  2025cites this paper
• Antidepressant‐Like Effects of Hydroxychavicol‐Enriched Piper betle L. Leaf Extract in Chronic Mild Stress–Induced Rodent Models and Possible Mechanism(s) of Action Involved

  2025cites this paper
• Association between comorbidity and chronic obstructive pulmonary disease: a systematic review and meta-analysis of Mendelian randomization studies

  2025cites this paper
• The impact of inflammatory response on psychological status of medical staff during COVID-19 pandemic

  2025cites this paper
• Suicide attempt predictors among adolescents exhibiting non-suicidal self-injury: A six-week follow-up open study

  2025cites this paper
• A novel sex-specific association between insulin resistance and depressive symptoms in older adults: The potential mediating role of Vascular Endothelial Growth Factor.

  2025cites this paper
• NLRP3 Inflammasome: A New Target for the Treatment of CVD and Depression Comorbidity

  2025cites this paper
• Changes in Geriatric Depression Scale scores in relation to physical performance, inflammatory status, and hippocampal atrophy over a 7-year follow-up: Data from the Pro.V.A. study.

  2025cites this paper
• Bidirectional relationship between C-reactive protein and depressive symptoms considering cumulative effect among Chinese middle-aged and older adults

  2024cites this paper
• Prediction of depressive symptoms at high age (80+) by psychological, biological and functional factors.

  2024cites this paper
• Adherence to a Mediterranean Diet Is Inversely Associated with Anxiety and Stress but Not Depression: A Cross-Sectional Analysis of Community-Dwelling Older Australians

  2024cites this paper
• Neuroinflammation and Brain Health Risks in Veterans Exposed to Burn Pit Toxins

  2024cites this paper
• Characteristics of and Risk Factors for Depressive Symptoms Preceding Dementia: A Study of 82‐Year‐Old Men From the Uppsala Longitudinal Study of Adult Men

  2024cites this paper
• Exosome-associated mitochondrial DNA in late-life depression: Implications for cognitive decline in older adults.

  2024cites this paper
• Anti-Amyloid Drugs for Alzheimer’s Disease: Considering the Role of Depression

  2024cites this paper
• Association of modifiable risk factors with progression to dementia in relation to amyloid and tau pathology

  2024cites this paper
• Association between depressive symptoms and cardiovascular diseases in the Korean geriatric population: A nationwide retrospective cohort study.

  2024cites this paper
• Mediating effect of social support and resilience between loneliness and depression in older adults: A systematic review and meta-analytic structural equation modeling.

  2024cites this paper
• Indoleamine 2,3-Dioxygenase as a Therapeutic Target for Alzheimer’s Disease and Geriatric Depression

  2023cites this paper
• Depressive and Biopsychosocial Frailty Phenotypes: Impact on Late-life Cognitive Disorders

  2023cites this paper
• Does acupuncture treatment have satisfactory clinical efficacy for late-life depression? A systematic review and meta-analysis.

  2023cites this paper
• Treatment resistant depression in elderly.

  2023cites this paper
• Biological factors influencing depression in later life: role of aging processes and treatment implications

  2023cites this paper
• Peripheral blood infl ammatory markers as signals of mental disorders in a sample of elderly people

  2023cites this paper
• Mild Behavioral Impairment

  2023cites this paper
• Plasma neurofilament light chain in association to late‐life depression in the general population

  2023cites this paper
• Relationship between depression severity and respiratory symptoms in US adults: A national cross-sectional study.

  2023cites this paper
• Depression in patients with cerebral microangiopathy

  2023cites this paper
• Personality predictors of dementia diagnosis and neuropathological burden: An individual participant data meta‐analysis

  2023cites this paper
• Neuroinflammation and depression: An update

  2023cites this paper
• Inflammation and Late-Life Depression: Unraveling the Complex Relationship and Potential Therapeutic Strategies.

  2023cites this paper
• Neurofilaments - small proteins of physiological significance and predictive power for future neurodegeneration and cognitive decline across the life span.

  2023cites this paper
• Plasminogen Activator Inhibitor-1: Potential Inflammatory Marker in Late-life Depression

  2023cites this paper
• Predictors of post‐stroke depression: the perspective from the social convoy model

  2023cites this paper
• Potential Explanatory Models of the Female Preponderance in Very Late Onset Schizophrenia

  2022cites this paper
• Neutrophil to lymphocyte ratio is a transdiagnostic biomarker of depression and structural and functional brain alterations in older adults.

  2022cites this paper
• Pharmacologic treatment of depression in Alzheimer’s disease

  2022cites this paper
• Correlations Between Inflammatory Biomarkers in Tuberculosis-Associated Obstructive Pulmonary Disease Patients With Anxiety and Depression

  2022cites this paper
• Relationships between Plasma Concentrations of Testosterone and Dihydrotestosterone and Geriatric Depression Scale Scores in Men and Women Aged 60–65 Years—A Multivariate Approach with the Use of Quade’s Test

  2022cites this paper
• Risk Prediction Models for Depression in Community-Dwelling Older Adults.

  2022cites this paper
• Resilience and mind-body interventions in late-life depression

  2022cites this paper
• Could Melatonin Be an Alternative to Benzodiazepine for Chronic Obstructive Pulmonary Disease With Insomnia?

  2022cites this paper
• Reward System Dysfunction and the Motoric-Cognitive Risk Syndrome in Older Persons

  2022cites this paper
• Pre-pandemic Physical Function and Social Network in Relation to COVID-19-Associated Depressive Burden in Older Adults in Sweden

  2022cites this paper
• C-reactive protein levels and depression in older and younger adults - A study of 19,947 individuals. The Tromsø study

  2022cites this paper
• Inflammatory markers and incident depression: Evidence in a population-based prospective study.

  2022cites this paper
• The NLRP3 inflammasome in depression: Potential mechanisms and therapies.

  2022cites this paper
• The sociodemographic characteristics and clinical features of the late-life depression patients: results from the Beijing Anding Hospital mental health big data platform

  2022cites this paper
• Excess body weight and specific types of depressive symptoms: Is there a mediating role of systemic low-grade inflammation?

  2022cites this paper
• Depressive symptoms in cognitively unimpaired older adults are associated with lower structural and functional integrity in a frontolimbic network

  2022cites this paper
• Therapeutic effect of Thymoquinone on behavioural response to UCMS and neuroinflammation in hippocampus and amygdala in BALB/c mice model

  2022cites this paper
• Dopamine, Immunity, and Disease

  2022cites this paper
• Inflammatory Markers of Geriatric Depression Response to Tai Chi or Health Education Adjunct Interventions.

  2022cites this paper
• Mediation Analyses of the Role of Apathy on Motoric Cognitive Outcomes

  2022cites this paper
• Influences of Dopaminergic System Dysfunction on Late-Life Depression

  2021cites this paper
• Effects of cardiorespiratory fitness and muscular strength on the association between arterial stiffness and depression in older adults

  2021cites this paper
• Depression among predictors of intermittent claudication: A cross-sectional study.

  2021cites this paper
• Erectile Dysfunction in Men with Chronic Obstructive Pulmonary Disease

  2021cites this paper
• Vascular depression in Black Americans: A systematic review of the construct and its cognitive, functional, and psychosocial correlates

  2021cites this paper
• Immune-endocrine biomarkers associated with mental health: a 9-year longitudinal investigation from the Hertfordshire Ageing Study.

  2021cites this paper
• Association Between Frailty-Related Factors and Depression among Older Adults

  2021cites this paper
• Longitudinal Impact of Frailty States and Sleep Duration on Subsequent Depressive Symptoms of Older Adults

  2021cites this paper
• Late-life depression and increased risk of dementia: a longitudinal cohort study

  2021cites this paper
• Inflammation, Negative Affect, and Amyloid Burden in Alzheimer's Disease: Insights from the Kynurenine Pathway.

  2021cites this paper
• Anxiety and depression among chronic obstructive pulmonary disease

  2021cites this paper
• Major Depressive Disorder in Older Patients as an Inflammatory Disorder: Implications for the Pharmacological Management of Geriatric Depression

  2021cites this paper
• Relationship between Handgrip Strength and Low-grade Inflammation in Older Adults with Depression

  2021cites this paper
• IL-6 and IL-8 are likely associated with psychological status in treatment naïve general population.

  2021cites this paper
• Use of Transcutaneous Auricular Vagus Nerve Stimulation as an Adjuvant Therapy for the Depressive Symptoms of COVID-19: A Literature Review

  2021cites this paper
• Do inflammation and adiposity mediate the association of diet quality with depression and anxiety in young adults?

  2021cites this paper
• A Lifespan Model of Interference Resolution and Inhibitory Control: Risk for Depression and Changes with Illness Progression

  2020cites this paper
• Effects of Capsinoids on Daily Physical Activity, Body Composition and Cold Hypersensitivity in Middle-Aged and Older Adults: A Randomized Study

  2020cites this paper
• EZH2 is involved in vulnerability to neuroinflammation and depression-like behaviors induced by chronic stress in different aged mice.

  2020cites this paper
• Resilience as a buffer against negative health sequelae in older gay men living with HIV/AIDS: implications for research and practice

  2020cites this paper
• Neural substrates for late-life depression: A selective review of structural neuroimaging studies.

  2020cites this paper
• Stress, mental health, and aging

  2020cites this paper
• Depression and Neurovascular Disease

  2020cites this paper
• Combinatorial PharmacogenomicTesting Improves Outcomes for Older Adults With Depression.

  2020cites this paper
• Inflammation is associated with future depressive symptoms among older adults

  2020cites this paper
• Chronic Systemic Inflammation Is Associated With Symptoms of Late-Life Depression: The ARIC Study.

  2020cites this paper
• Predicting the Risk of Depression in the Elderly by Immunological Indicators Research

  2020cites this paper
• The longitudinal associations of inflammatory biomarkers and depression revisited: systematic review, meta-analysis, and meta-regression

  2020cites this paper
• Study of Predictors of Quality of Life and its Association with Anxiety and Depression in Chronic Obstructive Pulmonary Disease in Industrial Workers

  2020cites this paper
• Physical frailty and the risk of major depressive disorder: The Irish Longitudinal Study on Ageing.

  2020cites this paper
• Water extract of Armillaria mellea (Vahl) P. Kumm. alleviates the depression-like behaviors in acute- and chronic mild stress-induced rodent models via anti-inflammatory action.

  2020cites this paper
• Neuroinflammation, Depressive Affect, and Amyloid Burden in Alzheimer's Disease: Insights from the Kynurenine Pathway

  2020cites this paper
• Cerebrovascular Disease, Aging, and Depression: Clinical Features, Pathophysiology, and Treatment

  2020cites this paper
• Dementia: Psychosocial/Mental Health Risk Factors

  2020cites this paper
• Linking depressive symptom dimensions to cerebellar subregion volumes in later life

  2020cites this paper
• Contributing Factors to Heterogeneity in the Timing of the Onset of Nonfatal Suicidal Behavior: Results From a Nationally Representative Study.

  2020cites this paper
• The complex interplay between depression and multimorbidity in late life: risks and pathways: Depression and Multimorbidity.

  2020cites this paper
• Pathomechanisms of Vascular Depression in Older Adults

  2020cites this paper
• Minocycline augmentation in older adults with persistent depression: an open label proof of concept study

  2020cites this paper
• Do late and early onset depression differ in terms of inflammation?

  2020cites this paper